SCHEMBL18376829

SCHEMBL18376829

CC(=O)N1CCN(c2cccc(Nc3ncc4cccc(-c5ccc(S(C)(=O)=O)cc5)c4n3)c2)CC1

nearest known ligand 0.60

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 1/20 0.60
▸ JAK2 O60674 14/20 0.56
▸ JAK3 P52333 13/20 0.56
▸ JAK1 P23458 2/20 0.56
▸ PTK2 Q05397 11/20 0.55
▸ ABCB1 P08183 1/20 0.54
▸ CYP3A4 P08684 1/20 0.54
▸ CCNT1 O60563 3/20 0.51
▸ CCNA2 P20248 3/20 0.51
▸ CDK2 P24941 3/20 0.51
▸ CDK9 P50750 3/20 0.51
▸ BRD4 O60885 2/20 0.51
▸ CDK1 P06493 2/20 0.51
▸ CCNB1 P14635 2/20 0.51
▸ FLT3 P36888 1/20 0.51
▸ CDK7 P50613 1/20 0.49
▸ CCNH P51946 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18376835 0.92 EGFR (0.58) EGFRJAK2JAK3JAK1PTK2
SCHEMBL29370824 0.91 EGFR (0.66) EGFRJAK2JAK3JAK1PTK2
SCHEMBL28696412 0.91 EGFR (0.66) EGFRJAK2JAK3JAK1PTK2
SCHEMBL18376249 0.91 EGFR (0.61) EGFRJAK2JAK3JAK1PTK2
SCHEMBL29368834 0.90 EGFR (0.62) EGFRJAK2JAK3JAK1CCNT1
SCHEMBL18376840 0.90 EGFR (0.62) EGFRJAK2JAK3JAK1CCNT1
SCHEMBL28696326 0.89 JAK2 (0.67) JAK2JAK3JAK1PTK2ABCB1
SCHEMBL18376831 0.89 EGFR (0.56) EGFRJAK2JAK3JAK1PTK2
SCHEMBL18376833 0.89 EGFR (0.56) EGFRJAK2JAK3JAK1PTK2
SCHEMBL18376844 0.89 EGFR (0.65) EGFRJAK2JAK3CCNT1CCNA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113999180-B Quinazoline compound, intermediate, preparation method, pharmaceutical composition and application 上海医药集团股份有限公司 2024-03-26 — — CN disclosed
WO-2017005137-A1 QUINAZOLINE COMPOUND, INTERMEDIATE, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USES THEREOF 吉林大学 2017-01-12 — — WO disclosed
Send feedback